 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.
SUMMARIES FOR PATIENTS
Risk for Cancer in Patients with Barrett Esophagus
18 April 2000 | Volume 132 Issue 8 | Page 612
Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians-American Society of Internal Medicine.
The summary below is from the full report titled "Effect of Segment Length on Risk for Neoplastic Progression in Patients with Barrett Esophagus.". It is in the 18 April 2000 issue of Annals of Internal Medicine (volume 132, pages 612-620). The authors are R.E. Rudolph, T.L. Vaughan, B.E. Storer, R.C. Haggitt, P.S. Rabinovitch, D.S. Levine, and B.J. Reid.
What is the problem and what is known about it so far?
Barrett esophagus is a condition in which the lining of the esophagus (the tube that connects the mouth to the stomach) becomes abnormal. This change may occur when stomach contents, including acid, rise up into the esophagus, a condition known as gastroesophageal reflux disease (GERD). The only way to know if a person has Barrett changes is to look at the esophagus with a special instrument that is passed through the mouth into the esophagus and stomach (a procedure called esophagogastroduodenoscopy, or EGD). Using this instrument, the doctor can also take samples of the esophageal lining to examine under a microscope. Most people who have GERD never develop Barrett esophagus, but those who do are at a higher risk for esophageal cancer. Many experts therefore recommend that people with Barrett esophagus get EGDs regularly to catch cancer in an early, more treatable stage. It has been thought that the greater the length of the esophagus that shows Barrett changes, the greater the chances of developing esophageal cancer, but this has never been shown for certain.
Why did the researchers do this particular study?
To see if the length of the esophagus affected by Barrett esophagus is related to a person's risk of developing cancer.
Who was studied?
The researchers studied 309 patients with Barrett esophagus at a teaching hospital in Seattle, Washington.
How was the study done?
The patients had an EGD at regular intervals. Barrett segment length was recorded at the time of the first EGD. The researchers looked for evidence of cancer on follow-up EGDs, and in 171 patients they also looked for abnormalities of esophageal lining cells thought to be precancerous. These precancerous abnormalities are known as aneuploidy.
What did the researchers find?
Patients with short Barrett segments were not found to have a lower risk for esophageal cancer than patients with long Barrett segments. However, patients with short Barrett segments were somewhat less likely to develop precancerous abnormalities than those with long Barrett segments.
What were the limitations of the study?
The researchers followed patients for an average of only about 4 years; the findings might have been different had they followed them longer. All participants received counseling on how to reduce GERD, and most used acid-lowering medicines regularly. The findings might be different in patients who received less intense treatment for GERD.
What are the implications of the study?
The risk for cancer in patients with short Barrett segments was not substantially lower than that in patients with longer segments. Until further information is available, doctors and patients should not consider Barrett segment length when making decisions about how often to check for cancer with EGD.
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  F. Yousef, C. Cardwell, M. M. Cantwell, K. Galway, B. T. Johnston, and L. Murray The Incidence of Esophageal Cancer and High-Grade Dysplasia in Barrett's Esophagus: A Systematic Review and Meta-Analysis Am. J. Epidemiol., August 1, 2008; 168(3): 237 - 249. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Jin, J. P. Hamilton, J. Yang, Y. Mori, A. Olaru, F. Sato, T. Ito, T. Kan, Y. Cheng, B. Paun, et al. Hypermethylation of the AKAP12 Promoter is a Biomarker of Barrett's-Associated Esophageal Neoplastic Progression Cancer Epidemiol. Biomarkers Prev., January 1, 2008; 17(1): 111 - 117. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Jin, A. Olaru, J. Yang, F. Sato, Y. Cheng, T. Kan, Y. Mori, C. Mantzur, B. Paun, J. P. Hamilton, et al. Hypermethylation of Tachykinin-1 Is a Potential Biomarker in Human Esophageal Cancer Clin. Cancer Res., November 1, 2007; 13(21): 6293 - 6300. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. DeMeester Adenocarcinoma of the Esophagus and Cardia: A Review of the Disease and Its Treatment Ann. Surg. Oncol., January 1, 2006; 13(1): 12 - 30. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Cook, C. P. Wild, and D. Forman A Systematic Review and Meta-Analysis of the Sex Ratio for Barrett's Esophagus, Erosive Reflux Disease, and Nonerosive Reflux Disease Am. J. Epidemiol., December 1, 2005; 162(11): 1050 - 1061. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. E. Rudolph, T. L. Vaughan, A. R. Kristal, P. L. Blount, D. S. Levine, P. C. Galipeau, L. J. Prevo, C. A. Sanchez, P. S. Rabinovitch, and B. J. Reid Serum Selenium Levels in Relation to Markers of Neoplastic Progression Among Persons With Barrett's Esophagus J Natl Cancer Inst, May 21, 2003; 95(10): 750 - 757. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Spechler A 59-Year-Old Woman With Gastroesophageal Reflux Disease and Barrett Esophagus JAMA, January 22, 2003; 289(4): 466 - 475. [Full Text] [PDF]
|
|
|
|
 |
|
 N L A Arents, J C Thijs, and J H Kleibeuker A rational approach to uninvestigated dyspepsia in primary care: review of the literature Postgrad. Med. J., December 1, 2002; 78(926): 707 - 716. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R J Playford Endoscopic surveillance of patients with Barrett's oesophagus Gut, September 1, 2002; 51(3): 314 - 315. [Full Text]
|
|
|
|
|
|
R C Fitzgerald, S Abdalla, B A Onwuegbusi, P Sirieix, I T Saeed, W R Burnham, and M J G Farthing Inflammatory gradient in Barrett's oesophagus: implications for disease complications Gut, September 1, 2002; 51(3): 316 - 322. [Abstract] [Full Text]
|
|
|
|
|
|
T. L. Vaughan, A. R. Kristal, P. L. Blount, D. S. Levine, P. C. Galipeau, L. J. Prevo, C. A. Sanchez, P. S. Rabinovitch, and B. J. Reid Nonsteroidal Anti-inflammatory Drug Use, Body Mass Index, and Anthropometry in Relation to Genetic and Flow Cytometric Abnormalities in Barrett's Esophagus Cancer Epidemiol. Biomarkers Prev., August 1, 2002; 11(8): 745 - 752. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Shaheen and D. F. Ransohoff Gastroesophageal Reflux, Barrett Esophagus, and Esophageal Cancer: Scientific Review JAMA, April 17, 2002; 287(15): 1972 - 1981. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Spechler Barrett's Esophagus N. Engl. J. Med., March 14, 2002; 346(11): 836 - 842. [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Wong, T. G. Paulson, L. J. Prevo, P. C. Galipeau, G. Longton, P. L. Blount, and B. J. Reid p16INK4a Lesions Are Common, Early Abnormalities that Undergo Clonal Expansion in Barrett's Metaplastic Epithelium Cancer Res., November 1, 2001; 61(22): 8284 - 8289. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. M. R. Campos, S. R. DeMeester, J. H. Peters, S. Oberg, P. F. Crookes, J. A. Hagen, C. G. Bremner, L. F. Sillin III, R. J. Mason, and T. R. DeMeester Predictive Factors of Barrett Esophagus: Multivariate Analysis of 502 Patients With Gastroesophageal Reflux Disease Arch Surg, November 1, 2001; 136(11): 1267 - 1273. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Segment Length and Risk of Neoplastic Progression in Barrett's Esophagus Journal Watch Gastroenterology, August 14, 2000; 2000(814): 2 - 2. [Full Text]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article
